BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16080524)

  • 1. p53 intronic G13964C variant in colon cancer and its association with HPV.
    Buyru N; Tezol A; Dalay N
    Anticancer Res; 2005; 25(4):2767-9. PubMed ID: 16080524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene mutations are rare in human papillomavirus-associated colon cancer.
    Buyru N; Budak M; Yazici H; Dalay N
    Oncol Rep; 2003; 10(6):2089-92. PubMed ID: 14534749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection.
    Sayhan N; Yazici H; Budak M; Bitisik O; Dalay N
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):25-34. PubMed ID: 11458982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is p53 intronic variant G13964C associated with predisposition to cancer?
    Fiszer-Maliszewska Ł; Kazanowska B; Kuśnierczyk P; Mańczak M; Niepiekło W; Pochroń-Zeman B; Nowakowska B
    J Appl Genet; 2003; 44(4):547-52. PubMed ID: 14617836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N; Altinisik J; Demokan S; Dalay N
    Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction.
    Pérez LO; Abba MC; Laguens RM; Golijow CD
    Colorectal Dis; 2005 Sep; 7(5):492-5. PubMed ID: 16108887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
    Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B
    J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
    Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
    Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
    Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
    Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer.
    Vonlanthen S; Kawecki TJ; Betticher DC; Pfefferli M; Schwaller B
    Anticancer Res; 2007; 27(6C):4279-88. PubMed ID: 18214032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
    Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
    Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
    Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
    Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p53 arginine polymorphism with skin cancer.
    de Oliveira WR; Rady PL; Grady J; Hughes TK; Neto CF; Rivitti EA; Tyring SK
    Int J Dermatol; 2004 Jul; 43(7):489-93. PubMed ID: 15230885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
    J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline polymorphism of p53 codon 72 in gynecological cancer.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
    Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran.
    Nadji SA; Mahmoodi M; Ziaee AA; Naghshvar F; Torabizadeh J; Yahyapour Y; Nategh R; Mokhtari-Azad T
    Lung Cancer; 2007 May; 56(2):145-51. PubMed ID: 17208332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 codon 72 polymorphism and HPV status in lung cancer.
    Buyru N; Altinisik J; Isin M; Dalay N
    Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
    Hoffmann M; Scheunemann D; Fazel A; Görögh T; Kahn T; Gottschlich S
    Oncol Rep; 2009 Mar; 21(3):809-14. PubMed ID: 19212643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia.
    Marsh A; Spurdle AB; Turner BC; Fereday S; Thorne H; Pupo GM; Mann GJ; Hopper JL; Sambrook JF; Chenevix-Trench G; ;
    Breast Cancer Res; 2001; 3(5):346-9. PubMed ID: 11597326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.